Where does Aileron Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aileron Therapeutics, Inc. ranks #8,972 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aileron Therapeutics, Inc. hold?

Aileron Therapeutics, Inc. holds 35 US utility patents granted between 2015 and 2021, spanning 9 technology areas.

What is Aileron Therapeutics, Inc.'s Innovation Score?

Aileron Therapeutics, Inc. has an Innovation Score of 38.0 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Aileron Therapeutics, Inc. focus on?

Aileron Therapeutics, Inc.'s top technology area is C07K (Peptides) with 33 patents, ranking #289 of 3,615 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Aileron Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Aileron Therapeutics, Inc.'s recent grant velocity is -79% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Aileron Therapeutics, Inc.'s patents?

Aileron Therapeutics, Inc.'s patents average 30.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aileron Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aileron Therapeutics, Inc.

USPTO PatentsView assignee record - 35 granted patents across 9 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aileron ranks #8,972 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 9 technology areas.

#8,972
of 49,997 US assignees by volume: Top 42%
by Innovation Score (38.0/100): 30.5
avg claims per patent: -79%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8972 · US Corporation #8,972 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 35 grants
UPPER-Q #8,972/49,997
PHOTO-FINISH Abengoa Solar New
CPC-NARROW C07K · 9 areas
INNOV-THIN 38.0/100
CLAIMS-DENSE 30.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -79% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Abengoa Solar New Technologies, S.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aileron’s 38.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (33%) Velocity 0.0 pts (0%) Breadth 10.6 pts (28%) Claim depth 15.0 pts (39%)

Qualcomm Incorporated · highest

85
Aileron Therapeutics · this assignee

38
Clarifai · near

38
GungHo Online… · near

38
Ictk Holdings · near

38
ODK Technology PTE · near

38
3D Lighting… · lowest

7

What this shows Aileron's Innovation Score is 38.0/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aileron?

Each dot is one of Aileron’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aileron’s own 30.5 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Aileron vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aileron's grants concentrate

Aileron Therapeutics, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 94.3% of grants classified under C07K (Peptides). Peak complete grant year is 2019 (9 grants) versus a trough of 2 in 2020. By volume, Aileron sits between AT&S(China) Co. Ltd. and Astellas Institute for Regenerative Medicine.

AT&S(China)

35
Axsome Malta

35
Abengoa Solar New

35
Achronix Semicond…

35
Akonia Holographi…

35
Altair Engineering

35
Amsterdam Printin…

35
Astellas Institut…

35
Aileron Therapeut… ◀

35

What this shows Aileron holds 35 patents at rank #8,977, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aileron

By rank, the assignees closest to #8,977 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Aileron's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Aileron, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Aileron ranks #289 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Clarifai, Inc. 38 GungHo Online Entertainment, Inc. 38 Ictk Holdings Co., Ltd. 38 ODK Technology PTE. Ltd. 38

Aileron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Aileron Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	20.0%
2016	5	14.3%
2017	3	8.6%
2018	5	14.3%
2019	9	25.7%
2020	2	5.7%
2021	4	11.4%

Which technologies does Aileron Therapeutics, Inc. patent most?

C07K - Peptides 33

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 30

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 25

C07C - Acyclic OR Carbocyclic Compounds 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aileron Therapeutics, Inc.'s patent record in context - here's where to go next.

Aileron Therapeutics, Inc.'s lead technology class is C07K (Peptides), 94.3% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #8,972 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aileron Therapeutics, Inc. against AT&S(China) Co. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.